Lundbeck
HLUN-B.CO
#2766
Rank
$4.63 B
Marketcap
$4.80
Share price
2.66%
Change (1 day)
3.23%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : $2.27 B

According to Lundbeck 's latest financial reports the company's total liabilities are $2.27 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lundbeck - Total liabilities on balance sheet (from 2009 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31$2.27 B-5.24%
2022-12-31$2.40 B-3.69%
2021-12-31$2.49 B-20.86%
2020-12-31$3.14 B-1.6%
2019-12-31$3.20 B138.52%
2018-12-31$1.34 B9.9%
2017-12-31$1.22 B-17.98%
2016-12-31$1.48 B-18.98%
2015-12-31$1.83 B-7.1%
2014-12-31$1.97 B5.07%
2013-12-31$1.88 B26.92%
2012-12-31$1.48 B9.75%
2011-12-31$1.35 B10.02%
2010-12-31$1.22 B-23.39%
2009-12-31$1.60 B70.27%
2008-12-31$0.94 B-6.4%
2007-12-31$1.00 B16.61%
2006-12-31$0.86 B31.74%
2005-12-31$0.65 B-1.97%
2004-12-31$0.66 B